X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ALEMBIC LTD - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS ALEMBIC LTD J.B.CHEMICALS/
ALEMBIC LTD
 
P/E (TTM) x 17.1 55.9 30.6% View Chart
P/BV x 2.3 2.3 99.3% View Chart
Dividend Yield % 0.2 0.4 38.3%  

Financials

 J.B.CHEMICALS   ALEMBIC LTD
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
ALEMBIC LTD
Mar-18
J.B.CHEMICALS/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs31872 441.8%   
Low Rs20034 588.5%   
Sales per share (Unadj.) Rs148.04.7 3,148.0%  
Earnings per share (Unadj.) Rs19.16.1 312.7%  
Cash flow per share (Unadj.) Rs23.96.2 383.4%  
Dividends per share (Unadj.) Rs0.500.20 250.0%  
Dividend yield (eoy) %0.20.4 51.1%  
Book value per share (Unadj.) Rs128.940.7 317.1%  
Shares outstanding (eoy) m84.82267.03 31.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.711.3 15.5%   
Avg P/E ratio x13.68.7 156.3%  
P/CF ratio (eoy) x10.88.5 127.5%  
Price / Book Value ratio x2.01.3 154.1%  
Dividend payout %2.63.3 80.0%   
Avg Mkt Cap Rs m21,95114,139 155.3%   
No. of employees `0002.7NA-   
Total wages/salary Rs m1,841207 887.8%   
Avg. sales/employee Rs Th4,590.9NM-  
Avg. wages/employee Rs Th673.4NM-  
Avg. net profit/employee Rs Th592.1NM-  
INCOME DATA
Net Sales Rs m12,5511,255 1,000.0%  
Other income Rs m542370 146.3%   
Total revenues Rs m13,0931,625 805.5%   
Gross profit Rs m2,055111 1,849.4%  
Depreciation Rs m41238 1,091.0%   
Interest Rs m962 5,629.4%   
Profit before tax Rs m2,088442 472.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46924 1,958.6%   
Profit after tax Rs m1,6191,630 99.3%  
Gross profit margin %16.48.9 185.0%  
Effective tax rate %22.55.4 414.4%   
Net profit margin %12.9129.8 9.9%  
BALANCE SHEET DATA
Current assets Rs m7,7781,867 416.6%   
Current liabilities Rs m4,358591 737.1%   
Net working cap to sales %27.2101.6 26.8%  
Current ratio x1.83.2 56.5%  
Inventory Days Days5594 58.0%  
Debtors Days Days8074 108.8%  
Net fixed assets Rs m5,7131,791 319.0%   
Share capital Rs m170534 31.8%   
"Free" reserves Rs m10,54710,324 102.2%   
Net worth Rs m10,93710,858 100.7%   
Long term debt Rs m041 0.0%   
Total assets Rs m15,57411,591 134.4%  
Interest coverage x22.8260.9 8.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.1 744.2%   
Return on assets %11.014.1 78.2%  
Return on equity %14.815.0 98.6%  
Return on capital %20.015.2 131.4%  
Exports to sales %48.71.5 3,152.2%   
Imports to sales %7.121.0 33.7%   
Exports (fob) Rs m6,11519 31,520.1%   
Imports (cif) Rs m889263 337.5%   
Fx inflow Rs m6,16919 31,799.0%   
Fx outflow Rs m1,285264 487.1%   
Net fx Rs m4,884-244 -1,998.2%   
CASH FLOW
From Operations Rs m1,397236 592.3%  
From Investments Rs m-320-224 143.0%  
From Financial Activity Rs m-1,196-27 4,495.5%  
Net Cashflow Rs m-102-15 691.2%  

Share Holding

Indian Promoters % 55.4 64.0 86.6%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.2 1,695.0%  
FIIs % 3.9 9.7 40.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 26.1 141.8%  
Shareholders   30,437 54,701 55.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DISHMAN PHARMA  ELDER PHARMA  VENUS REMEDIES  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY18); Net Profit Up 64.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ALEMBIC LTD has posted a net profit of Rs 46 m (up 64.9% YoY). Sales on the other hand came in at Rs 332 m (up 0.9% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Sep 21, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - VENUS REMEDIES COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS